Steven Weber - 12 Mar 2024 Form 4 Insider Report for IGM Biosciences, Inc. (IGMS)

Role: PRINCIPAL ACCOUNTING OFFICER
Signature: /s/ Misbah Tahir, by power of attorney
Issuer symbol: IGMS
Transactions as of: 12 Mar 2024
Net transactions value: $0
Form type: 4
Filing time: 14 Mar 2024, 18:27:54 UTC
Previous filing: 06 Apr 2023
Next filing: 15 Mar 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	IGMS	Common Stock	Award	$0	+18,750	+214%	$0.000000	27,500	12 Mar 2024	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	IGMS	Stock Option (right to buy)	Award	$0	+37,500		$0.000000	37,500	12 Mar 2024	Common Stock	37,500	$9.95	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. One-sixteenth of the RSUs shall vest on June 12, 2024 and each three-month anniversary thereafter, provided that the Reporting Person remains a service provider through each vesting date.
F2	One forty-eighth of the shares subject to the option shall vest on April 12, 2024 and each month thereafter, provided that the Reporting Person remains a service provider through each vesting date.